Sustained improvements in motor and non-motor symptoms in advanced Parkinson's disease patients treated with carbidopa levodopa enteral suspension in a ‘real-world’ study

K Ray Chaudhuri,Jason Aldred,David Standaert,Norbert Kovacs,Francesco Pontieri,Paul Bourgeois,Thomas Davis,Esther Cubo,Marieta Anca-Herschkovitsch,Robert Iansek,Mustafa Siddiqui,Mihaela Simu,Lars Bergmann,Pavnit Kukreja,Weining Robieson

doi:10.1016/j.jns.2021.119562

Abstract

We evaluate effect of levodopa–carbidopa intestinal gel(LCIG, carbidopa-levodopa enteral suspension[CLES] in USA)on motor and nonmotor symptoms in a multi-country observational study in advanced Parkinson's disease (PD) patients treated with LCIG in routine clinical practice.

Full Text